follow-up, there is no difference regarding second primary malignancies between groups. In conclusion, the 2 + 2 regimen spares a significant number of patients from the burden of relapse and additional treatment without increased long-term toxicity.

Deutsche Krebshilfe eV and Swiss Federal Government.

Deutsche Krebshilfe eV and Swi…[Read more]